Sanofi Ventures
Investment Details
Investor Type
Corporate VC
Asset Class Focus
Venture Capital
Stage Focus
Seed, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, Brazil, France, Italy, Denmark, Switzerland, Spain, Mexico, South Korea, Netherlands, South Africa, Russia, Sweden, Belgium
Industries Focus
- Healthcare
- Artificial Intelligence
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Regenerative Medicine
- Oncology
- Neurology
- Vaccines
- Immunology
- Rare Diseases
- Data Science
- Cell and Gene Therapy
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2012
Sanofi Ventures is the corporate venture capital arm of Sanofi, investing globally in early-stage biotech and digital health companies aligned with Sanofi’s mission.
Since its inception in 2012, Sanofi Ventures has deployed over $800 million across more than 70 innovative companies in biotech and digital health. The fund focuses on areas such as immunology, rare diseases, neurology, and vaccines, investing across all stages of the private company lifecycle, from Seed to Series B and beyond. Sanofi Ventures leads financings, serves on boards, and works alongside portfolio companies to drive long-term value.
In September 2025, Sanofi committed an additional $625 million to Sanofi Ventures, increasing its total assets under management to over $1.4 billion. This commitment aims to accelerate investment in biotech and digital health innovation, supporting Sanofi’s long-term growth strategy. The fund's evergreen structure allows it to invest in early-stage companies that are too early to partner with or acquire, serving as an entry point to the innovation ecosystem for Sanofi.
Sanofi Ventures has a diverse, globally distributed portfolio of companies advancing innovation around the world. The fund's strategic importance is highlighted by its recent performance, including three realized exits in 2024 with a combined acquisition value of $3.25 billion. By providing essential financial backing and strategic support, Sanofi Ventures plays a crucial role in advancing healthcare innovation and reinforcing Sanofi’s position as a leading catalyst for breakthrough science in healthcare.
Requirements
- Focus on biotech and digital health companies
- Alignment with Sanofi’s mission
- Early-stage companies
- Potential for long-term value creation
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Formation Bio
- Vigil Neuroscience
- Vicebio
Mentioned In
-
$9.95
-
$19.95
-
$39.95
-
$24.95
-
$19.95
-
$24.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Sanofi Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim